Journals / Viral Hepatitis Journal / 2016 / Cilt: 22 - Sayı: 2

Can Detection of Non-alcoholic Fatty Liver Disease be Coincidental in Young Patients with Chronic Hepatitis B?

Genç Kronik Hepatit B Hastalarında Alkolik Olmayan Yağlı Karaciğer Hastalığı Saptanması Rastlantısal Olabilir mi?

Pages
43–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We found that HBsAg positivity is not correlated with the development of NAFLD in young patients, and coexistence of NAFLD and HBV might be coincidental.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The objective of this study was to determine the factors associated with the presence of non-alcoholic fatty liver disease (NAFLD) in young persons who are hepatitis B surface antigene (HBsAg)-positive and negative, and to investigate if NAFLD coexisting hepatitis B virus (HBV) is coincidental.
📊
Key Findings & Data:Materials and Methods: This retrospective study, conducted in a military hospital in Turkey, included a total of 384 subjects.
💡
Conclusion & Impact:Conclusion: We found that HBsAg positivity is not correlated with the development of NAFLD in young patients, and coexistence of NAFLD and HBV might be coincidental.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The objective of this study was to determine the factors associated with the presence of non-alcoholic fatty liver disease (NAFLD) in young persons who are hepatitis B surface antigene (HBsAg)-positive and negative, and to investigate if NAFLD coexisting hepatitis B virus (HBV) is coincidental. Materials and Methods: This retrospective study, conducted in a military hospital in Turkey, included a total of 384 subjects. The subjects were divided into two groups according to the presence of NAFLD detected by ultrasonography (US). Sociodemographic characteristics, biochemical, histopathological, virological and US results were recorded . Statistical analysis was performed using SPSS 22.0. Results: The median age of the patients, all of whom were male, was 26 years . NAFLD was identified in 16.9% of patients. HBsAg positivity was found in 36.9% of patients with NAFLD. It was remarkable that no statistically significant difference was found in HBsAg positivity between the patients with and without NAFLD (p=0.661). NAFLD was found in 13.2% of HBsAg-positive patients. NAFLD was determined in 20.3% of HBsAg-negative patients. No significant difference was found in NAFLD grades between HBsAg-positive and negative patients (p=0.158). In the present study, only ?-glutamyl transferase in HBsAg positive patients, and age, alanine transaminase and aspartate transaminase in HBsAg negative patients were determined as the most important factors associated with the presence of NAFLD. Conclusion: We found that HBsAg positivity is not correlated with the development of NAFLD in young patients, and coexistence of NAFLD and HBV might be coincidental.

Özet

Amaç: Bu araştırmanın amacı hepatit B yüzey antijeni (HBsAg) pozitif ve negatif genç hastalarda alkolik olmayan yağlı karaciğer hastalığının (AOYKH) sıklığını, AOYKH oluşumu ile ilişkili faktörleri ve hepatit B virüsü (HBV) ile AOYKH'nin birlikte saptanmasının rastlantısal olup olmadığını ortaya koymaktı. Gereç ve Yöntemler: Bu retrospektif çalışma bir askeri hastanede yapıldı. Çalışmaya toplam 384 hasta dahil edildi. Hastalar ultrasonografik (US) olarak saptanan AOYKH'na göre iki gruba ayrıldı. Grupların sosyodemografik, biyokimyasal, histopatolojik, virolojik ve US bulguları retrospektif olarak kaydedildi. SPSS 22,0 kullanılarak istatistiksel analizleri yapıldı.Bulgular: Tümü erkek olan hastaların yaş ortancası 26 yıl (20-40 yıl) saptandı. Hastaların %16,9'unda AOYKH tanımlandı. AOYKH olan hastaların %36,9'unda HBsAg pozitifliği saptandı. AOYKH olan ve olmayan hastalar arasında HBsAg pozitifliği açısından istatistiksel olarak önemli fark saptanmadı (p=0,661). HBsAg pozitif hastaların %13,2'sinde, HBsAg negatif hastaların %20,3'ünde AOYKH belirlendi. HBsAg pozitif ve negatif hastalar arasında AOYKH açısından önemli fark bulunmadı (p=0,158). HBsAg pozitif hastalarda ?-glutamil transferaz, HBsAg negatif hastalarda yaş, alanin transaminaz ve aspartat transaminaz AOYKH varlığı ile ilişkili en önemli faktörler olarak belirlendi.Sonuç: Bu çalışmada HBsAg pozitifliğinin genç hastalarda AOYKH gelişimi ile ilişkili olmadığını, HBV ve AOYKH birlikteliğinin rastlantısal olabileceğini saptadık.

🔖

Cite This Article

KARACAER, Z., OKUR, G., ÇERMİK, A. H., AVCI, Ö. (2016). Can Detection of Non-alcoholic Fatty Liver Disease be Coincidental in Young Patients with Chronic Hepatitis B?. Viral Hepatitis Journal, Cilt: 22 - Sayı: 2, 43–47. https://ajindex.com/articles/332808

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Altay T, Uskun E, Akcam FZ. Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey. Braz J Infect Dis 2012;16:339-344
  2. Türk Karaciğer Araştırmaları Derneği Ulusal Hepatit Sıklığı Çalışması (TÜRKHEP2010), www.tasl.org.tr/dosya/tasl_Ulusal_ Hepatit_sikligi_Calismasi.pdf
  3. Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012;2012:145754
  4. Nascimento AC, Maia DR, Neto SM, Lima EM, Twycross M, Baquette RF, Lobato CM. Nonalcoholic Fatty liver disease in chronic hepatitis B and C patients from Western Amazon. Int J Hepatol 2012;2012:695950
  5. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008;23:779-782
  6. Uyanıkoğlu A, Coşkun M, Binici DN, Öztürk Y. The frequency of hepatosteatosis in inactive hepatitis B carries. Viral Hepatitis Journal 2011;17:62-65
  7. Altıparmak E, Koklu S, Yalinkilic M, Yuksel O, Cicek B, Kayacetin E, Sahin T. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol 2005;28;11:3056-3059
  8. Lesmana LA, Lesmana CR, Pakasi LS, Krisnuhoni E. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity. Acta Med Indones 2012;44:35-39
  9. Peng D, Han Y, Ding H, Wei L. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol 2008;23:1082-1088
  10. Cindoruk M, Karakan T, Unal S. Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection. J Clin Gastroenterol 2007;41:513-517
  11. Incedayı M, Pekkafali MZ, Sildiroglu HO, Basekim CC, Kizilkaya E. Sonographic and histopathological correlation in diffused fatty liver. Anatol J Clin Investig 2012;6:1-5
  12. Ishak KG, Zimmerman HJ. Morphologic spectrum of druginduced hepatic disease. Gastroenterol Clin North Am 1995;24:759-786
  13. Celebi S, Ataseven H, Mengucuk E, Deveci SH, Acık Y, Bahcecioglu İH. Epidemic features of nonalcoholic fatty liver in urban community of Elazıg. Akademik Gastroenteroloji Dergisi 2006;5:41-46
  14. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010;28:155-161
  15. Inci A, Meral CE. Ultrasonographic Assessment of the Prevalence of Hepatic Steatosis in Inactive Hepatitis B Carriers. Viral He